WallStreetZenWallStreetZen

NASDAQ: BTAI
Bioxcel Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Bioxcel Therapeutics earnings were -$40.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest BTAI earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$7.3M, down 33.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BTAI reported annual earnings of -$59.6M, with -66.7% growth.

BTAI earnings history

Current Revenue
$1.9M
Current Earnings
-$40.1M
Current Profit Margin
-2,163.2%

BTAI Return on Equity

Current Company
N/A
Current Industry
-59.8%
Current Market
29%

BTAI undefined

Current Company
-83.8%
Current Industry
0.1%
BTAI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when BTAI announces earnings.

BTAI undefined

Current Company
-188.53%
Current Industry
7.9%
BTAI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BTAI vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
BTAI-$24.24M-$40.06MN/A-$12.85
NEUPN/A-$1.81MN/A-$2.56
PRTG-$76.75M-$67.32MN/A-$64.64
ACXP-$11.87M-$11.87MN/A-$0.70
SNSE-$26.33M-$29.03MN/A-$1.15
View Top Biotech Stocks

Bioxcel Therapeutics Earnings Reports & History FAQ

What were Bioxcel Therapeutics's earnings last quarter?

On BTAI's earnings call on Invalid Date, Bioxcel Therapeutics (NASDAQ: BTAI) reported Q1 2025 earnings per share (EPS) of -$1.50, up 89.2% year over year. Total BTAI earnings for the quarter were -$7.25 million. In the same quarter last year, Bioxcel Therapeutics's earnings per share (EPS) was -$13.89.

If you're new to stock investing, here's how to buy Bioxcel Therapeutics stock.

Is Bioxcel Therapeutics profitable or losing money?

As of the last Bioxcel Therapeutics earnings report, Bioxcel Therapeutics is currently losing money. Bioxcel Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$40.06 million, a 73.82% decrease year over year.

What was BTAI's earnings growth in the past year?

As of Bioxcel Therapeutics's earnings date in Invalid Date, Bioxcel Therapeutics's earnings has grown year over year. BTAI earnings in the past year totalled -$40.06 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.